Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_assertion description "[Thirty-six of 59 patients (61.0%) with esophageal cancer had detectable levels of methylated DAPK or APC promoter DNA and preoperative detection was significantly associated with an unfavorable prognosis as revealed by multivariate Cox proportional hazards regression analysis [Exp(b) = 4.578; P = 0.01].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_assertion evidence source_evidence_literature NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_assertion SIO_000772 19259700 NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_assertion wasDerivedFrom befree-20140225 NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_assertion wasGeneratedBy ECO_0000203 NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP869634.RADP33A_O6L9cIk7GLfhe_sMGqN-E3xarfDxIdrT9dP9E130_provenance.